Authors
Latest:
Paxlovid’s Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load ReboundThe conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.
Latest:
Small Companies Can Face Challenges When Conducting Clinical TrialsConducting clinical trials to investigate claims regarding supplements' safety and efficacy can support greater patient wellness.
Latest:
Interest Grows in Long-Acting Injectables for HIV TreatmentContinued advancements in therapy may expand its use to larger patient population, though challenges remain
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Hospitals Can Leverage Data From Second-Generation Technology for More Effective Drug Diversion PreventionAI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.
Latest:
Changes in the Law Result From OTC Drug Product TamperingChicago Tylenol murders still reverberates after 40 years; they changed medication packaging forever.
Latest:
Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile RatesAntimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Latest:
Shorter Course of Treatment for CAP in Children Demonstrates SuccessPediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
Latest:
Precision in Practice: Optimizing Probability of Beta-Lactam Target Attainment with Prolonged Infusions and Therapeutic Drug MonitoringAs data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.
Latest:
Multilingual Medicine: A Pharmacist’s Impact on Inclusive Health CarePatricia Gutierrez, PharmD, BCACP, CDE, aims to combat the challenges in culturally competent care with knowledge and love for her community and patients.
Latest:
Migraine Awareness Month: A Pharmacist’s Role in Dynamic ManagementThe increased negative health outcomes associated with migraines provide an opportunity for pharmacists in both the inpatient and outpatient setting to support patients.
Latest:
Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic PopulationPh-like ALL may be predominantly prevalent in Hispanic and Latino populations.
Latest:
How Integrating Research Into Private Pharmacy Practice Can Support Care and Diversity in Clinical TrialsBy taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.
Latest:
Artificial Intelligence Applications in Education and Pharmacy PracticeBy interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Latest:
How Integrating Clinical Trials Into Private Practice Can Benefit Both Patients, PhysiciansHaving scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.
Latest:
Pain Management in the ICU Is ComplexFinding the right medication or drug combination for individual patients is critical.
Latest:
Future-Proofing Pharmacies Amid a Changing Health Care LandscapeNew tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.
Latest:
Benefit of Adjuvant Abemaciclib in High-Risk Early Breast Cancer Is Sustained at 5 YearsThe therapy sustained IDFS benefit compared with ET alone.
Latest:
‘First Day Cover’ Collection Marks 50th Anniversary of Pharmacy StampAmerican Institute of the History of Pharmacy posts the collection of pharmacist Daniel Shifrin on its website.
Latest:
Bridging the Gap: How Pharmacists Can Expand and Transform Mental Health ServicesThis expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.
Latest:
Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication AdherenceOffering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.
Latest:
Siremadlin Demonstrates Efficacy, Safety in Treatment of Patients With TP53 Wild-Type Chronic Lymphocytic LeukemiaSiremadlin is a novel, investigational, second-generation antagonist that binds to MDM2.
Latest:
John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.
Latest:
Pharmacy-Led Enhanced Patient Education in the Emergency DepartmentIn this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Latest:
TXNIP inhibitors: A New Class of Agents for Diabetes TreatmentTXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
